CVS Health Corp. buy JPMorgan Chase & Co.
Summary
This prediction ended on 19.02.26 with a price of €65.84. The BUY prediction by JPMorgan_Chase___Co_ finished with a performance of 5.13%. JPMorgan_Chase___Co_ has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | -1.067% | -1.067% | -0.846% |
| iShares Core DAX® | 0.751% | -8.496% | 2.575% |
| iShares Nasdaq 100 | -1.405% | -2.771% | 15.682% |
| iShares Nikkei 225® | 0.417% | -9.291% | 29.655% |
| iShares S&P 500 | -0.590% | -2.868% | 9.963% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.